Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $36 | $27 | -$15 | $27 |
| Dep. & Amort. | $18 | $18 | $17 | $17 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $10 | $14 | -$5 | $5 |
| Other Non-Cash | -$3 | $14 | $40 | -$3 |
| Operating Cash Flow | $61 | $73 | $37 | $46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$9 | -$25 | -$36 |
| Net Acquisitions | $0 | -$0 | -$3 | -$3 |
| Inv. Purchases | $0 | -$0 | -$1 | -$1 |
| Inv. Sales/Matur. | $0 | $4 | $2 | $4 |
| Other Inv. Act. | -$2 | -$0 | -$0 | $1 |
| Investing Cash Flow | -$8 | -$6 | -$27 | -$35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | -$2 | $4 | $20 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$38 | -$17 | -$26 | -$0 |
| Dividends Paid | -$12 | -$12 | -$13 | -$12 |
| Other Fin. Act. | $0 | -$3 | -$3 | -$3 |
| Financing Cash Flow | -$53 | -$34 | -$37 | $6 |
| Forex Effect | -$1 | $4 | $2 | $4 |
| Net Chg. in Cash | $93 | $37 | -$25 | $20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $95 | $58 | $83 | $63 |
| End Cash | $93 | $95 | $58 | $83 |
| Free Cash Flow | $54 | $62 | $13 | $10 |